Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07288346

Effect of Predictive Model on Double-Balloon Enteroscopy

Effect of Predictive Model on Total Double-Balloon Enteroscopy Rate: a Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
338 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to assess the effect of predictive model on total enteroscopy rate in double-balloon enteroscopy.

Detailed description

Double-balloon enteroscopy is a new and effective endoscopic technique used for the diagnosis and treatment of small intestinal diseases. Due to its deep intubation ability, it can achieve complete visualization of the small intestinal mucosa, that is, total enteroscopy. Theoretically, a higher total enteroscopy rate could be associated with a greater possibility of detecting positive lesions. However, a total enteroscopy is a challenging procedure for endoscopists. Endoscopists cannot accurately predict the operational difficulty of patients before the operation, which leads to the passivity of preoperative preparation and intraoperative strategy formulation. Recently, the Department of Gastroenterology of Qilu Hospital of Shandong University has completed the development and external validation of the first double-balloon enteroscopy prediction model. A preoperative individualized assessment of the difficulty of total enteroscopy can be achieved using this model. Therefore, a multicenter randomized controlled study was designed to assess the performance of predictive model in double-balloon enteroscopy, including total enteroscopy rate, positive findings, procedural time, adverse events and other indicators.

Conditions

Interventions

TypeNameDescription
OTHERPredictive modelEndoscopists obtain the patient's predictive model scores before double-balloon enteroscopy.

Timeline

Start date
2026-01-12
Primary completion
2027-05-31
Completion
2027-08-31
First posted
2025-12-17
Last updated
2026-01-13

Locations

5 sites across 1 country: China

Source: ClinicalTrials.gov record NCT07288346. Inclusion in this directory is not an endorsement.